TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ:MSLE, TSX:MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today the results of its Annual Meeting of Shareholders held June 17, 2026 (the "Meeting"). Satellos is pleased to announce that all the nominees listed in the management information circular dated May 14, 2026 (the "Circular") were elected as directors. Shareholders present at the Meeting or represented by proxy totaled 55.3% of the issued and outstanding common shares of the Company. The results of the vote are detailed below: DirectorVotes Fo
- Satellos Bioscience Announces Results of Annual Meeting of Shareholders
- Gord Johnston to Transition to Vice Chair of Stantec's Board of Directors
EDMONTON, Alberta and NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- TSX, NYSE:STN Stantec, a global leader in sustainable design and engineering, announces today that Gord Johnston will retire as president and chief executive officer, effective October 1. Mr. Johnston will remain on the Board, taking on the role of vice chair. Susan Reisbord, currently chief operating officer of the North America business, has been appointed as the next president and chief executive officer. "Susan is a proven leader with a strong track record of delivering results," said Doug Ammerman, chair of Stantec's Board of Directors. "Under Susan's leadership, Stantec is well positioned to deliver on its commitment
- Director Steinberg Joseph S bought $660,530 worth of shares (40,882 units at $16.16), increasing direct ownership by 60% to 108,500 units (SEC Form 4)
4 - Vitesse Energy, Inc. (0001944558) (Issuer)
- Co-Founder & CEO Schlacks Jabbok bought $1,056,039 worth of shares (50,000 units at $21.12) (SEC Form 4)
4 - EquipmentShare.com Inc (0001693736) (Issuer)
- CEO and Chairman Pujari Roshen sold $1,645 worth of shares (861 units at $1.91), decreasing direct ownership by 0.17% to 501,910 units (SEC Form 4) to satisfy tax liability
4 - Stardust Power Inc. (0001831979) (Issuer)
- Chief Accounting Officer Stuart Cormac sold $1,667,537 worth of Ordinary Shares (11,644 units at $143.21), closing all direct ownership in the company (SEC Form 4)
4 - AerCap Holdings N.V. (0001378789) (Issuer)
- Director Amin Avinash disposed of 42,500 shares, decreasing direct ownership by 59% to 30,000 units (SEC Form 4)
4 - Neuronetics, Inc. (0001227636) (Issuer)
- Co-Founder & President Schlacks William J. bought $1,073,500 worth of shares (50,000 units at $21.47) (SEC Form 4)
4 - EquipmentShare.com Inc (0001693736) (Issuer)
- Director Bienaime Jean Jacques bought $10,190 worth of shares (1,000 units at $10.19), increasing direct ownership by 6% to 17,592 units (SEC Form 4)
4 - Keros Therapeutics, Inc. (0001664710) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A
4 - Forte Biosciences, Inc. (0001419041) (Issuer)
- Chief Financial Officer Whitney David Kirk converted options into 562,500 shares, increasing direct ownership by 375% to 712,500 units (SEC Form 4)
4 - Starfighters Space, Inc. (0001947016) (Issuer)
- SEC Form 4 filed by Officer Wagner Paul A.
4 - Forte Biosciences, Inc. (0001419041) (Issuer)